Liver Cancer News
The daily liver cancer news is a unique cancer news service that evaluates all aspects of liver cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for liver cancer prevention, early detection and liver cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making liver cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Liver Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Liver Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking statins (cholesterol-lowering drugs), according to the results of a study published in the Journal of... Continue Reading
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading
Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the... Continue Reading
The use of antiviral drugs to treat patients with hepatitis C could greatly reduce their risk of developing liver cancer, according to the results of a study published in BMJ Open. The liver is the largest... Continue Reading
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading
In a recent Web Chat on CancerConnect.com, Dr. Boris Kuvshinoff II and Dr. Renuka Iyer, Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer Institute, presented a review of treatment... Continue Reading
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading
Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are Co-Directors... Continue Reading
Liver cancer incidence has increased over time in the United States, and chronic infection with the hepatitis C virus now plays an important role in many cases. These results were published in Mayo Clinic... Continue Reading
Latest Liver Cancer News By Stage
Screening/Prevention
Statins Linked to Lower Risk of Liver Cancer in Hepatitis C (May 8, 2013)
People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking statins (cholesterol-lowering drugs), according to the results of a study published in the Journal of Clinical Oncology.[1] The liver is the largest organ... Continue Reading
Antiviral Therapy for Hepatitis C May Prevent Liver Cancer (November 2, 2012)The use of antiviral drugs to treat patients with hepatitis C could greatly reduce their risk of developing liver cancer, according to the results of a study published in BMJ Open. The liver is the largest organ in the body and is responsible for over... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
Study Identifies Risk Factors Including Hepatitis C and Alcohol for Developing Hepatocellular Carcinoma (Liver Cancer) (March 12, 2012)Liver cancer incidence has increased over time in the United States, and chronic infection with the hepatitis C virus now plays an important role in many cases. These results were published in Mayo Clinic Proceedings. The liver is the largest organ in... Continue Reading
Organ Transplant Recipients Have Increased Cancer Risk (November 9, 2011)People who have received a solid organ transplant (such as a kidney or liver) are twice as likely as people in the general population to develop cancer. These results were published in the Journal of the American Medical Association. In 2010, more than... Continue Reading
More Screening and PreventionStages I-III
Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)
Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the results of a study published in the Journal of the... Continue Reading
Today at 6 PM EST Watch CancerConnect Web Chat with the Experts on Liver Cancer (March 20, 2012)Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center... Continue Reading
CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer... Continue Reading
Nexavar Superior to Sutent in Liver Cancer (June 23, 2011)Nexavar® (sorafenib) provides superior overall survival to Sutent® (sunitinib) in the treatment of hepatocellular (liver) cancer. These results were presented at the 2011 annual American Society of Clinical Oncology (ASCO) meeting. Hepatocellular carcinoma... Continue Reading
Combination Chemotherapy Improves Survival with Biliary Tract Cancer (May 17, 2010)According to the results of a Phase III clinical trial, treatment of locally advanced or metastatic biliary tract cancer with a combination of Gemzar® (gemcitabine) and cisplatin results in better survival and a lower risk of cancer progression than... Continue Reading
More Stages I and IIIStage IV
Factors Affecting Quality of Life at the End of Life (July 20, 2012)
For people with advanced cancer, quality of life at the end of life—sometimes referred to as “a good death”—may have less to do with medical treatment and more to do with a therapeutic alliance with their physicians, according to the results of... Continue Reading
Today at 6 PM EST Watch CancerConnect Web Chat with the Experts on Liver Cancer (March 20, 2012)Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center... Continue Reading
CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer... Continue Reading
Nexavar Superior to Sutent in Liver Cancer (June 23, 2011)Nexavar® (sorafenib) provides superior overall survival to Sutent® (sunitinib) in the treatment of hepatocellular (liver) cancer. These results were presented at the 2011 annual American Society of Clinical Oncology (ASCO) meeting. Hepatocellular carcinoma... Continue Reading
Cabozantinib Shows Promise against Bone Metastases (May 31, 2011)The investigational drug cabozantinib is showing promise against several types of advanced cancer, and may also reduce or eliminate bone metastases (cancer that has spread to the bone) in some patients. These results will be presented at the 2011 annual... Continue Reading
More Stage IVRecurrent
CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)
Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer... Continue Reading
Cabozantinib Shows Promise against Bone Metastases (May 31, 2011)The investigational drug cabozantinib is showing promise against several types of advanced cancer, and may also reduce or eliminate bone metastases (cancer that has spread to the bone) in some patients. These results will be presented at the 2011 annual... Continue Reading
Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading
Arterial Embolization Effective in Patients with Liver Cancer Recurrence (June 26, 2006)Arterial Embolization Effective in Patients with Liver Cancer Recurrence In selected patients who have a cancer recurrence following surgical removal of liver cancer, arterial embolization (blocking the arteries that supply blood to a tumor) appears to... Continue Reading
Repeat Surgery for Recurrent Liver Cancer Provides Long-Term Survival in Subset of Patients (October 30, 2003)Repeat Surgery for Recurrent Liver Cancer Provides Long-Term Survival in Subset of Patients According to results recently published in the Annals of Surgery, repeat surgery for recurrent liver cancer provides long-term survival in a subset of... Continue Reading
More RecurrentHepatocellular Carcinoma
Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)
Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the results of a study published in the Journal of the... Continue Reading
Oncology Experts Talk About Surgery, Ablation, Embolization, Radiation Therapy, Chemotherapy, and Clinical Trials for Primary Hepatocellular Carcinoma (Liver Cancer) (April 20, 2012)In a recent Web Chat on CancerConnect.com, Dr. Boris Kuvshinoff II and Dr. Renuka Iyer, Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer Institute, presented a review of treatment options for primary liver cancer. Each year in... Continue Reading
Today at 6 PM EST Watch CancerConnect Web Chat with the Experts on Liver Cancer (March 20, 2012)Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center... Continue Reading
CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer... Continue Reading
Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were published in Lancet Oncology. Hepatocellular carcinoma... Continue Reading
More Hepatocellular Carcinoma
